当前位置: 首页 > 详情页

Expression and prognostic significance of TAp73 and Delta Np73 in FIGO stage I-II cervical squamous cell carcinoma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Departments of Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China [2]Departments of Radiotherapy and Oncology,The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China [3]Departments of Pathology,The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China
出处:
ISSN:

关键词: cervical cancer p73 prognosis

摘要:
The purpose of the present study was to investigate the expression of TAp73 and Delta Np73 in cervical squamous cancer cells, and to evaluate the prognostic significance of TAp73 and Delta Np73 expression in patients with International Federation of Gynecology and Obstetrics (FIGO) stage I-II cervical squamous cell carcinoma (SCC). The immunohistochemical expression of TAp73 and Delta Np73 was evaluated in 59 FIGO stage I-II cervical SCC tumor samples. Correlations with clinicopathological characteristics were determined by chi(2) test. The prognostic impact of TAp73 and Delta Np73 expression with regard to overall survival (OS) was determined by the Kaplan-Meier method. High TAp73 and Delta Np73 expression was detected in 79.7% (47/59) and 76.3% (45/59) of patients, respectively. The expression of TAp73 and Delta Np73 was not associated with age, FIGO stage, pathological differentiation or lymph node metastasis. The 3-year OS rates associated with low and high TAp73 expression were 75.0 and 83.0%, respectively (chi(2)=0.33; P=0.568), whereas those associated with low and high Delta Np73 expression were 100.0 and 75.6%, respectively (chi(2)=3.90; P=0.048). High expression levels of TAp73 and Delta Np73 were frequently observed in the cervical squamous cancer cells. Overall, high expression levels of Delta Np73 may indicate an unfavorable prognosis in patients with early-stage cervical SCC.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2013]版:
Q4 ONCOLOGY
最新[2023]版:
Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Departments of Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China
通讯作者:
通讯机构: [*1]Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu 215004, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院